Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alder biopharmaceuticals
3
×
biotech
3
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
clinical trials
eli lilly
fda
indiana blog main
indiana top stories
novartis
roche
ubiome
vertex pharmaceuticals
abeona therapeutics
accent therapeutics
achilles therapeutics
advaxis
What
bio
drug
new
roundup
advantages
amgen
approval
bar
big
bosley's
bosley’s
bridge
brings
bucks
candidates
cas
ceo
class
crime
crispr
departure
developed
editas
exit
expect
fda
gamble
gets
guiding
head
katrine
market
medco’s
medicine
medicines
migraine
mover
moves
nod
pain
Language
unset
Current search:
biotech
×
" alder biopharmaceuticals "
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
